Civic Intelligence

Stemexpress Foundation

990 • Fiscal year 2016 • EIN 90-0782885

Jan 01, 2016 to Dec 31, 2016

Folsom, CA
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

95th percentile

1.28x

Higher debt load relative to assets than 95% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2016

Liabilities / Revenue

49th percentile

0.10x

Higher debt load relative to revenue than 49% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2016

Net Margin

35th percentile

-2.1%

Higher net margin than 35% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2016

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2016

Asset Growth

100th percentile

7959200%

Faster asset growth than 100% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2015 to 2016

Revenue Growth

Score unavailable

No value available

A valid growth rate could not be computed from the available filing history.

Annualized from 2015 to 2016

Assets

Up

$79,593

Up $79,592 (+7959200%) from 2015

Net Assets

-$22,020

No earlier filing loaded for comparison.

Liabilities

Up

$101,613

Up $101,613 from 2015

Revenue

Up

$1,026,606

Up $1,026,606 from 2015

Expenses

Up

$1,048,626

Up $1,048,626 from 2015

Net Income

Down

-$22,020

Down $22,020 from 2015

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$600K$400K$200K$0-$200KAssets 2015: $1Liabilities 2015: $02015Assets 2016: $79,593Liabilities 2016: $101,613Net Assets 2016: -$22,0202016Assets 2017: $104,612Liabilities 2017: $62,357Net Assets 2017: $42,2552017Assets 2018: $84,593Liabilities 2018: $72,231Net Assets 2018: $12,3622018Assets 2019: $108,473Liabilities 2019: $91,686Net Assets 2019: $16,7872019Assets 2020: $38,189Liabilities 2020: $53,785Net Assets 2020: -$15,5962020Assets 2021: $222,954Liabilities 2021: $415,140Net Assets 2021: -$192,1862021Assets 2022: $260,501Liabilities 2022: $419,605Net Assets 2022: -$159,1042022Assets 2023: $74,770Liabilities 2023: $135,424Net Assets 2023: -$60,6542023Assets 2024: $24,632Liabilities 2024: $90,645Net Assets 2024: -$66,0132024

Highlighted filing

2016

Assets$79,593
Liabilities$101,613
Net Assets-$22,020

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.5M$1.0M$500K$0-$500KRevenue 2015: $0Expenses 2015: $0Net Income 2015: $02015Revenue 2016: $1,026,606Expenses 2016: $1,048,626Net Income 2016: -$22,0202016Revenue 2017: $620,726Expenses 2017: $556,451Net Income 2017: $64,2752017Revenue 2018: $590,842Expenses 2018: $620,735Net Income 2018: -$29,8932018Revenue 2019: $744,803Expenses 2019: $740,378Net Income 2019: $4,4252019Revenue 2020: $463,698Expenses 2020: $496,081Net Income 2020: -$32,3832020Revenue 2021: $249,620Expenses 2021: $426,210Net Income 2021: -$176,5902021Revenue 2022: $411,072Expenses 2022: $370,565Net Income 2022: $40,5072022Revenue 2023: $121,035Expenses 2023: $22,585Net Income 2023: $98,4502023Revenue 2024: $0Expenses 2024: $5,359Net Income 2024: -$5,3592024

Highlighted filing

2016

Revenue$1,026,606
Expenses$1,048,626
Net Income-$22,020
Filing Detail Status

This 2016 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2016 to Dec 31, 2016
Mission and Program Overview

Mission

Our mission is to address, educate, coordinate and provide significant change and improvement from medical research to patient outcomes by educating leaders, elected and appointed officials the importance of medical research, future of medicine and patient advocacy, advocate and support medical research advancement through grants, serve to reduce the burdens of government on organizations when it comes to research, clinical trials and FDA approval.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings